SKINCURE ONCOLOGY

SKINCURE ONCOLOGY filed a Q4 report for SKINCURE ONCOLOGY on January 16, 2026.

Lobbying for SKINCURE ONCOLOGY · Provider of non-surgical treatment option for skin cancer patients

All filings by SKINCURE ONCOLOGY · Everything SKINCURE ONCOLOGY has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Jan 20, 2026.

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 16, 2026

Expenses

$120,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Illinois

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Education and provision of information regarding Image Guided Superficial Radiation therapy (IGSRT) while working on a coverage policy with CMS for IGSRT.

Medicare/Medicaid

Education and provision of information regarding Image Guided Superficial Radiation therapy (IGSRT) while working on a coverage policy with CMS for IGSRT.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.